Literature DB >> 29736304

The contrasting roles of inflammasomes in cancer.

Qin He1, Yu Fu2, Dean Tian1, Wei Yan1.   

Abstract

Chronic inflammation plays a decisive role at different stages of cancer development. Inflammasomes are oligomeric protein complexes activated in response to pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). PAMPs and DAMPs are released from infected cells, tumors and damaged tissues. Inflammasomes activate and release inflammatory cytokines such as IL-1β and IL-18. The various inflammasomes and inflammatory cytokines and chemokines play contrasting roles in cancer development and progression. In this review, we describe the roles of different inflammasomes in lung, breast, gastric, liver, colon, and prostate cancers and in glioblastomas.

Entities:  

Keywords:  Inflammasomes; cancer; immune system; tumor microenvironment

Year:  2018        PMID: 29736304      PMCID: PMC5934549     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  176 in total

1.  IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis.

Authors:  Lin Wang; Ling-Fei Zhang; Jing Wu; Shu-Jun Xu; Yang-Yang Xu; Dangsheng Li; Jia-Tao Lou; Mo-Fang Liu
Journal:  Cancer Res       Date:  2014-06-23       Impact factor: 12.701

2.  Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition.

Authors:  Michail Mamantopoulos; Francesca Ronchi; Filip Van Hauwermeiren; Sara Vieira-Silva; Bahtiyar Yilmaz; Liesbet Martens; Yvan Saeys; Stefan K Drexler; Amir S Yazdi; Jeroen Raes; Mohamed Lamkanfi; Kathy D McCoy; Andy Wullaert
Journal:  Immunity       Date:  2017-08-08       Impact factor: 31.745

3.  [Effect of interleukin-18 gene modified human umbilical cord mesenchymal stem cells on proliferation of breast cancer cell].

Authors:  Suyuan Sun; Xiaoyi Liu; Dandan Jiang; Zhidong Lü; Funian Li
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2014-07-08

4.  Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis.

Authors:  C Ning; Y-Y Li; Y Wang; G-C Han; R-X Wang; H Xiao; X-Y Li; C-M Hou; Y-F Ma; D-S Sheng; B-F Shen; J-N Feng; R-F Guo; Y Li; G-J Chen
Journal:  Mucosal Immunol       Date:  2015-03-04       Impact factor: 7.313

Review 5.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

6.  Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis.

Authors:  Y Wang; K Wang; G-C Han; R-X Wang; H Xiao; C-M Hou; R-F Guo; Y Dou; B-F Shen; Y Li; G-J Chen
Journal:  Mucosal Immunol       Date:  2014-01-15       Impact factor: 7.313

7.  Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.

Authors:  L Wu; C Zhang; X Wang; X Ding; J Deng; H Liang
Journal:  Clin Transl Oncol       Date:  2015-08-11       Impact factor: 3.405

8.  Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression.

Authors:  Qing Wei; Kun Mu; Tao Li; Ying Zhang; Zhaowen Yang; Xiaoqing Jia; Wei Zhao; Wanwan Huai; Pengbo Guo; Lihui Han
Journal:  Lab Invest       Date:  2013-10-28       Impact factor: 5.662

9.  Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats.

Authors:  Gang Xu; Xiao-Dan Jiang; Ying Xu; Jing Zhang; Fan-Heng Huang; Zhen-Zhou Chen; De-Xiang Zhou; Jiang-Hua Shang; Yu-Xi Zou; Ying-Qian Cai; Sheng-Bin Kou; Yi-Zhao Chen; Ru-Xiang Xu; Yan-Jun Zeng
Journal:  Cell Biol Int       Date:  2008-08-06       Impact factor: 3.612

10.  S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β.

Authors:  Benjamin Weichand; Rüdiger Popp; Sarah Dziumbla; Javier Mora; Elisabeth Strack; Eiman Elwakeel; Ann-Christin Frank; Klaus Scholich; Sandra Pierre; Shahzad N Syed; Catherine Olesch; Julia Ringleb; Bilge Ören; Claudia Döring; Rajkumar Savai; Michaela Jung; Andreas von Knethen; Bodo Levkau; Ingrid Fleming; Andreas Weigert; Bernhard Brüne
Journal:  J Exp Med       Date:  2017-07-24       Impact factor: 14.307

View more
  25 in total

1.  The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth.

Authors:  Brian A Boone; Pranav Murthy; Jennifer L Miller-Ocuin; Xiaoyan Liang; Kira L Russell; Patricia Loughran; Meinrad Gawaz; Michael T Lotze; Herbert J Zeh; Sebastian Vogel
Journal:  Ann Hematol       Date:  2019-04-24       Impact factor: 3.673

2.  Mitochondrial Oxidative Phosphorylation Complex Regulates NLRP3 Inflammasome Activation and Predicts Patient Survival in Nasopharyngeal Carcinoma.

Authors:  I-Che Chung; Lih-Chyang Chen; Ngan-Ming Tsang; Wen-Yu Chuang; Tzu-Chieh Liao; Sheng-Ning Yuan; Chun-Nan OuYang; David M Ojcius; Chih-Ching Wu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2019-11-13       Impact factor: 5.911

Review 3.  Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis.

Authors:  Qing Bi; Ji-Yue Wu; Xue-Meng Qiu; Jian-Dong Zhang; Ze-Jia Sun; Wei Wang
Journal:  J Immunol Res       Date:  2022-06-13       Impact factor: 4.493

4.  Promoter methylation status of ASC/TMS1/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC).

Authors:  Maja Šutić; Antje Motzek; Gordana Bubanović; Matthias Linke; Ivan Sabol; Oliver Vugrek; Petar Ozretić; Luka Brčić; Sven Seiwerth; Željko Debeljak; Antonija Jakovčević; Zoran Janevski; Dinko Stančić-Rokotov; Andrea Vukić-Dugac; Marko Jakopović; Miroslav Samaržija; Ulrich Zechner; Jelena Knežević
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 5.  Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

6.  Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer.

Authors:  Yang Hu; Baraa K Manasrah; Stephanie M McGregor; Robert F Lera; Roshan X Norman; John B Tucker; Christina M Scribano; Rachel E Yan; Mouhita Humayun; Kari B Wisinski; Amye J Tevaarwerk; Ruth M O'Regan; Lee G Wilke; Beth A Weaver; David J Beebe; Ning Jin; Mark E Burkard
Journal:  Mol Cancer Ther       Date:  2021-09-28       Impact factor: 6.261

Review 7.  The NLRP1 Inflammasome in Human Skin and Beyond.

Authors:  Gabriele Fenini; Tugay Karakaya; Paulina Hennig; Michela Di Filippo; Hans-Dietmar Beer
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

Review 8.  Crosstalks between inflammasome and autophagy in cancer.

Authors:  Chaeuk Chung; Wonhyoung Seo; Prashanta Silwal; Eun-Kyeong Jo
Journal:  J Hematol Oncol       Date:  2020-07-23       Impact factor: 17.388

Review 9.  Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications.

Authors:  Jens Staal; Rudi Beyaert
Journal:  Cells       Date:  2018-08-29       Impact factor: 6.600

10.  New insights into the association between AXIN2 148 C/T, 1365 C/T, and rs4791171 A/G variants and cancer risk.

Authors:  Bin Xu; Wei Yuan; Li Shi; Li Zuo; Xing-Yu Wu; Wei Zhang; Qiaxian Wen
Journal:  Cancer Cell Int       Date:  2019-05-06       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.